The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery

Sponsor
Columbia University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02767427
Collaborator
Orthopaedic Scientific Research Foundation Inc (Other)
40
1
2
54.2
0.7

Study Details

Study Description

Brief Summary

The study team hypothesizes that at-home cleansing of the surgical site with chlorhexidine wipes provide no added benefit to decreasing microbial activity or preventing surgical site infections.

Patients will be randomized to the chlorhexidine or no additional intervention groups. Patients will be randomized to use 4% chlorhexidine cloths, while the other half receive no additional intervention. Those randomized into the chlorhexidine gluconate (CHG) home-application group will be asked to shower the night before surgery, and to use a standardized pre-packaged CHG wipe (that the patients would receive at their pre-surgical consultation) on their surgical site after thoroughly drying those areas. The patients will be asked to use a second wipe in each area the morning of surgery. The surgical sites will be analyzed in two groups: anterior cervical and posterior spine. Each of these two groups will be randomized separately. All patients will undergo a standardized preoperative cleansing regimen. Once positioned, they will be cleansed with an alcohol solution. Then, the surgical site (either the anterior portion of the neck or the posterior area of the spine) will be scrubbed with chlorhexidine soaked brushes and then painted with chlorhexidine solution. Perioperative antibiotics will be given per attending surgeon preference. Cutaneous samples will be taken from the surgical site of each patient at each time point.

Condition or Disease Intervention/Treatment Phase
  • Device: Chlorhexidine Wipes
  • Other: No intervention
N/A

Detailed Description

To the investigator's knowledge no prior study has evaluated the effects of cleaning the skin at home before surgery in patients undergoing spine surgery. This study will investigate whether patients who use a chlorhexidine cleansing wipe have decreased amounts of bacteria on their skin when they arrive for scheduled spine surgery. Spine surgeons strive to decrease infections in their patients, so it is important to see if this intervention helps to do this.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Prevention
Official Title:
The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
May 31, 2018
Anticipated Study Completion Date :
Aug 7, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: At-Home Chlorhexidine

Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep.

Device: Chlorhexidine Wipes
(Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site.
Other Names:
  • 4% Chlorhexidine Wipes
  • Chlorhexidine Gluconate
  • Skin Prep Cloths
  • Sage Skin Prep Cloths
  • Experimental: No At-Home Chlorhexidine

    Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively.

    Other: No intervention
    Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.

    Outcome Measures

    Primary Outcome Measures

    1. Number of Patients With Cutaneous Bacterial Load After Surgery [Pre-Surgery and Post Surgery, up to 4 hours]

      All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years old or older

    • Scheduled for elective spine surgery at Columbia University Medical Center

    Exclusion Criteria:
    • Unable to apply at-home chlorhexidine wipe by themselves

    • Deemed "high risk" preoperatively by the treating surgeon

    • Diagnosed with spine trauma

    • Undergoing deformity correction surgery

    • Unable to consent to the terms of the surgery

    • Known infection at time of the index procedure

    • Hospitalized within 1 week pre-operatively

    • Allergic to chlorhexidine

    • Immunocompromised

    • End stage renal disease on dialysis

    • Local or systemic skin disease (such as psoriasis, eczema, etc.)

    • Open skin wounds

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University Irving Medical Center New York New York United States 10034

    Sponsors and Collaborators

    • Columbia University
    • Orthopaedic Scientific Research Foundation Inc

    Investigators

    • Principal Investigator: Kiehyun D Riew, MD, Columbia University

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Kiehyun Riew, Professor of Orthopedic Surgery at the Columbia University Medical Center, Columbia University
    ClinicalTrials.gov Identifier:
    NCT02767427
    Other Study ID Numbers:
    • AAAP8304
    First Posted:
    May 10, 2016
    Last Update Posted:
    Feb 18, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Kiehyun Riew, Professor of Orthopedic Surgery at the Columbia University Medical Center, Columbia University
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title At-Home Chlorhexidine No At-Home Chlorhexidine
    Arm/Group Description Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.
    Period Title: Overall Study
    STARTED 21 19
    COMPLETED 21 19
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title At-Home Chlorhexidine No At-Home Chlorhexidine Total
    Arm/Group Description Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate (CHG) wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure. Total of all reporting groups
    Overall Participants 21 19 40
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    18
    85.7%
    12
    63.2%
    30
    75%
    >=65 years
    3
    14.3%
    7
    36.8%
    10
    25%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    56.05
    (9.12)
    59.79
    (13.10)
    57.87
    (11.39)
    Sex: Female, Male (Count of Participants)
    Female
    7
    33.3%
    6
    31.6%
    13
    32.5%
    Male
    14
    66.7%
    13
    68.4%
    27
    67.5%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    0
    0%
    2
    10.5%
    2
    5%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    1
    4.8%
    2
    10.5%
    3
    7.5%
    White
    19
    90.5%
    14
    73.7%
    33
    82.5%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    1
    4.8%
    1
    5.3%
    2
    5%
    Region of Enrollment (Count of Participants)
    United States
    21
    100%
    19
    100%
    40
    100%

    Outcome Measures

    1. Primary Outcome
    Title Number of Patients With Cutaneous Bacterial Load After Surgery
    Description All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours.
    Time Frame Pre-Surgery and Post Surgery, up to 4 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title At-Home Chlorhexidine No At-Home Chlorhexidine
    Arm/Group Description Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.
    Measure Participants 21 19
    Subjects with bacterial colonies
    0
    0%
    18
    94.7%
    Subjects without bacterial colonies
    21
    100%
    1
    5.3%
    Subjects with bacterial colonies
    0
    0%
    0
    0%
    Subjects without bacterial colonies
    21
    100%
    19
    100%
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection At-Home Chlorhexidine, No At-Home Chlorhexidine
    Comments
    Type of Statistical Test Equivalence
    Comments An equivalence test on data from a parallel-group design with sample sizes of 18 in the reference group and 18 in the treatment group achieves 80% power. The significance was set at 5%. The standard deviation was 1.00, and the equivalence limits were set at -1.00 and 1.00.
    Statistical Test of Hypothesis p-Value <0.05
    Comments
    Method t-test, 1 sided
    Comments Two one-sided t-tests were conducted with 18 in each group.

    Adverse Events

    Time Frame The forty enrolled patients were all consented and followed for data collection over the span of 15 months. Each patient was followed for up to 6 weeks after surgery to ensure that there were no postoperative infections.
    Adverse Event Reporting Description
    Arm/Group Title At-Home Chlorhexidine No At-Home Chlorhexidine
    Arm/Group Description Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.
    All Cause Mortality
    At-Home Chlorhexidine No At-Home Chlorhexidine
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/21 (0%) 0/19 (0%)
    Serious Adverse Events
    At-Home Chlorhexidine No At-Home Chlorhexidine
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/21 (0%) 0/19 (0%)
    Other (Not Including Serious) Adverse Events
    At-Home Chlorhexidine No At-Home Chlorhexidine
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/21 (0%) 0/19 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery
    Organization Columbia University
    Phone 212-932-4410
    Email kr2637@cumc.columbia.edu
    Responsible Party:
    Kiehyun Riew, Professor of Orthopedic Surgery at the Columbia University Medical Center, Columbia University
    ClinicalTrials.gov Identifier:
    NCT02767427
    Other Study ID Numbers:
    • AAAP8304
    First Posted:
    May 10, 2016
    Last Update Posted:
    Feb 18, 2020
    Last Verified:
    Feb 1, 2020